Results for “ ”

Entry Author Date Location
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug 09/15/20 San Francisco
Silence Therapeutics Taps Orchard’s Mark Rothera as President & CEO 09/14/20 Europe
Synlogic Names Metera’s David Hava as Chief Scientific Officer 09/14/20 Boston
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Satsuma Pharma’s Migraine Drug Fails to Beat Placebo in Phase 3 Test 09/10/20 San Francisco
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs 09/10/20 Boston
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Agios Exec Andrew Hirsch Jumps to C4 Therapeutics for CEO Role 09/08/20 Boston
AlloVir Taps Merck’s Atillasoy as Chief Regulatory & Safety Officer 09/08/20 Boston
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Q&A: BIO CEO Michelle McMurray-Heath Outlines Diversity Goals 09/05/20 National
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally 09/03/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
New Podcast and Special Report Explore How AI Is Revolutionizing Drug Discovery and Development 09/02/20 National
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25% 09/01/20 New York
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Akcea Therapeutics Is Returning to Parent Ionis Pharma in $500M Buyout 08/31/20 Boston
Nestlé to Swallow Up Peanut Allergy Drug Maker Aimmune in $2.6B Deal 08/31/20 San Francisco
The Legendary The Wakanda King Chadwick Boseman Died at 43 08/30/20 National
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests 08/27/20 Seattle
Page 4 of 2143 « previous page · next page »